Skip to content
Immunophotonics
  • About
    • Team
    • Board of Directors
    • Advisory Board
    • Highlighted Co-Inventor
    • Collaborators
  • Technology
  • Interventional Immuno-Oncology®
  • Pipeline
    • Colorectal Cancer (CRC)
    • Non-Small Cell Lung Cancer (NSCLC)
    • Melanoma
    • Soft Tissue Sarcoma (STS)
    • Hepatocellular Carcinoma (HCC)
    • Pancreatic Cancer
    • Vaccine Adjuvant
  • Patients
  • News & Media
  • Contact Us
Menu

News

404

News & Media

  •          
  • Print
Home » News & Media
March 20, 2024

AngioDynamics International Life Symposium “The Human Touch, Behind Innovation” March 21–23, 2024

Latest News
Tomas Hode, PhD, who serves as the Co-Founder, CIO, and President at Immunophotonics, Inc. is eager to attend the AngioDynamics...
Read More
March 13, 2024

MOBIO to feature Immunophotonics as the Member Highlight for March

Latest News
Immunophotonics to be showcased as the Member Highlight for March by The Missouri Biotechnology Association (MOBIO), both on their homepage...
Read More
February 28, 2024

AngioDynamics and Immunophotonics Announces Partnership to Explore the Power of Immunotherapy

Latest News, Press Releases
Immunophotonics Lu Alleruzzo, CEO and Tomas Hode, PhD, CIO, and President have announced a partnership that will combine use of...
Read More
February 23, 2024

Immunophotonics presenting at the Global Life Science Partnering & Investor Conference February 27-29, 2024

Latest News
Immunophotonics, Inc. is grateful to NCI (National Cancer Institute) SBIR Investor Initiatives Team for providing us the opportunity to showcase...
Read More
February 13, 2024

Wei Chen’s Publication in Acta Biomaterialia Journal

Latest News
Congratulations to Professor Wei Chen and his lab at the University of Oklahoma, along with contributors Lu Alleruzzo, Samuel S.K....
Read More
January 9, 2024

St. Louis cancer drug startup’s expansion plans include research pact with pharma giant

Latest News, Press Releases
St. Louis cancer drug startup Immunophotonics Inc. will pursue expansion of its lead drug candidate through a partnership with the...
Read More
January 24, 2024

SIO Annual Scientific Meeting, January 26 – 29, 2024

Latest News
Tomas Hode, PhD, Co-Founder, CIO, and President at Immunophotonics, Inc. will be attending the SIO Annual Scientific Meeting January 26...
Read More
January 9, 2024

Spectrum Conference, January 11 – 14, 2024

Latest News
Immunophotonics co-founders Lu Alleruzzo (CEO) and Tomas Hode, PhD (CIO and President) are looking forward to attending Spectrum Conference, January...
Read More
January 8, 2024

JPM 2024 San Francisco, January 8 – 12, 2024

Latest News
Our networking is well underway with investors and potential strategic partners for the JPM 2024.  Attending the annual summit Lu...
Read More
December 21, 2023

Immunophotonics Announces Research Collaboration to Study Combination of Its Lead Asset with Radiotherapy

Latest News, Press Releases
Immunophotonics Lu Alleruzzo, CEO and Tomas Hode, PhD, CIO, and President have announced a research collaboration with Johnson & Johnson...
Read More
« Previous 1 2 3 4 5 6 … 11 Next »
Contact us for more info and updates
  • About
  • Team
  • Board of Directors
  • Advisory Board
  • Highlighted Co-Inventor
  • Collaborators
  • Technology
  • Pipeline
  • Colorectal Cancer (CRC)
  • Non-Small Cell Lung Cancer (NSCLC)
  • Melanoma
  • Soft Tissue Sarcoma (STS)
  • Hepatocellular Carcinoma (HCC)
  • Pancreatic Cancer
  • Vaccine Adjuvant
  • Patients
  • Background
  • Trial Summary

Quick Links

  • Interventional Immuno-Oncology®
  • News & Media
  • Careers
  • Contact Us
  • Privacy Policy
  • Site Map
© Immunophotonics, Inc. All Rights Reserved
Terms of Use | FCOI Policy
Website by Axxiem
Scroll to top
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept All”, you consent to the use of ALL the cookies. However, you may visit "Cookie Settings" to provide a controlled consent.
Cookie SettingsAccept All
Manage consent

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.
CookieDurationDescription
cookielawinfo-checkbox-necessary11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-functional11 monthsThe cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-performance11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
cookielawinfo-checkbox-analytics11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-others11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
viewed_cookie_policy11 monthsThe cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
Functional
Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.
Performance
Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
Analytics
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
Advertisement
Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.
Others
Other uncategorized cookies are those that are being analyzed and have not been classified into a category as yet.
SAVE & ACCEPT